| Login | Register

About IBIS-II Prevention

1. Background to the Study
2. IBIS-II Study
3. Why investigate anastrozole in the prevention of breast cancer?
4. Examining anastrozole’s effect on women’s bones
5. Who can take part

IBIS-II Study

• Researchers are recruiting 6,000 post-menopausal women worldwide at a high risk of breast cancer.
• The study has been designed to investigate whether anastrozole can be used effectively to prevent breast cancer, based on comparison with a dummy drug (placebo).
• Women on the trial will either take anastrozole or placebo for 5 years.
• The IBIS-II trial will be recruiting women until December 2010. The first set of results is expected in 2012.